Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eucommia capsule is a traditional Chinese medicine (TCM) preparation primarily composed of the bark of *Eucommia ulmoides* Oliver. It is traditionally used to tonify the liver and kidneys, strengthen the sinews and bones, and alleviate pain in the lower back and knees. In clinical settings, it is often investigated for its efficacy in treating lumbar disc herniation, osteoporosis, and hypertension. The pharmacological effects are attributed to its bioactive constituents, including iridoids, lignans, and flavonoids, which exhibit anti-inflammatory, analgesic, and osteoprotective properties. In the context of lumbar disc herniation, it is frequently evaluated as part of a TCM regimen that may include manual manipulation therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on eucommia capsule.